Symbol="CBIO"
AssetType="Common Stock"
Name="Catalyst Biosciences Inc"
Description="Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, is focused on developing candidates for protease products in the fields of hemostasis and complement regulation. The company is headquartered in South San Francisco, California."
CIK="1124105"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="611 GATEWAY BLVD., SUITE 710, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="13291200"
EBITDA="-20133000"
PERatio="1.667"
PEGRatio="0.02"
BookValue="-0.687"
DividendPerShare="0"
DividendYield="0"
EPS="0.21"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.429"
ReturnOnEquityTTM="0.381"
RevenueTTM="0"
GrossProfitTTM="-64906000"
DilutedEPSTTM="0.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="16"
TrailingPE="1.667"
ForwardPE="-"
PriceToSalesRatioTTM="4.822"
PriceToBookRatio="0.527"
EVToRevenue="4.975"
EVToEBITDA="-0.592"
Beta="1.393"
num_52WeekHigh="1.294"
num_52WeekLow="0.189"
num_50DayMovingAverage="0.31"
num_200DayMovingAverage="0.353"
SharesOutstanding="37974900"
DividendDate="2023-01-12"
ExDividendDate="2023-01-13"
symbol="CBIO"
open="0.35"
high="0.37"
low="0.35"
price="0.36"
volume="146059.00"
latest_trading_day="2023-08-03"
previous_close="0.35"
change="0.01"
change_percent="2.8571%"
aroon_positive_momentum_days="43"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="438904"
Change_recent_avg="0.01"
Delta_recent_avg="0.02"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-1.47"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="489"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0116.jpeg"
image_negative_thumbnail_id_2="1135"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0168.jpeg"
image_neutral_thumbnail_id_1="565"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_neutral_thumbnail_id_2="557"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_positive_thumbnail_id_1="679"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0029.jpeg"
image_positive_thumbnail_id_2="994"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
